← Back to all trials
Active Not Recruiting
NCT05112237
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Conditions: Cardiomyopathy
Sex: All
Ages: 0 Years – 18 Years
Healthy volunteers: No
Enrollment: 200
Sponsor: Tenaya Therapeutics
Location: Arkansas Children's Hospital Little Rock Arkansas
Summary
The objective of this study is to collect information on patients with cardiomyopathy (CM) due to mutations in the MYBPC3 gene, to evaluate their disease course, burden of illness, risk factors for this disease, and the quality of life (QoL). This study will also collect information on treatments, procedures and outcome in infants and children up to 18 yrs who have this mutation.
Eligibility Criteria
Retrospective
Inclusion Criteria:
* Data is available for patient \
Source: ClinicalTrials.gov (NCT05112237). StuddyBuddy aggregates publicly available trial information.
